We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

400 hedge funds and large institutions have $6.44B invested in United Therapeutics in 2017 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 135 increasing their positions, 139 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 32

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

26% more capital invested

Capital invested by funds: $5.13B → $6.44B (+$1.31B)

7% more funds holding

Funds holding: 373 → 400 (+27)

0.49% more ownership

Funds ownership: 100.54% → 101.03% (+0.49%)

3% less repeat investments, than reductions

Existing positions increased: 135 | Existing positions reduced: 139

11% less call options, than puts

Call options by funds: $20.4M | Put options by funds: $23M

Holders
400
Holders Change
+27
Holders Change %
+7.24%
% of All Funds
9.07%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.14%
New
62
Increased
135
Reduced
139
Closed
32
Calls
$20.4M
Puts
$23M
Net Calls
-$2.55M
Net Calls Change
-$45.6M

Top Buyers

1
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB)
Sweden
+$47.1M
2
WCM
Wedge Capital Management
North Carolina
+$39.8M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$24.4M
4
Renaissance Technologies
Renaissance Technologies
New York
+$24.1M
5
Fidelity International
Fidelity International
Bermuda
+$20.8M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$43.6M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$31.4M
3
AQR Capital Management
AQR Capital Management
Connecticut
-$31.4M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$24.2M
5
State Street
State Street
Massachusetts
-$21.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
BCM
26
Bridgeway Capital Management
Texas
$45.7M +$623K +4,900 +2%
KAM
27
Krensavage Asset Management
New York
$43.6M -$6.62M -52,082 -15%
Invesco
28
Invesco
Georgia
$41.6M -$8.87M -69,810 -20%
LSV Asset Management
29
LSV Asset Management
Illinois
$40.6M +$13M +102,565 +60%
Russell Investments Group
30
Russell Investments Group
United Kingdom
$39.8M -$10.8M -85,340 -24%
Millennium Management
31
Millennium Management
New York
$36.5M -$8.84M -69,513 -22%
DZ Bank
32
DZ Bank
Germany
$36M +$5.75M +45,193 +23%
Prudential Financial
33
Prudential Financial
New Jersey
$34.8M -$257K -2,024 -0.9%
Royal Bank of Canada
34
Royal Bank of Canada
Ontario, Canada
$32.6M -$1.04M -8,172 -4%
AC
35
Armistice Capital
New York
$29.6M +$6.36M +50,000 +33%
Los Angeles Capital Management
36
Los Angeles Capital Management
California
$28.5M +$19.8M +155,520 +423%
Robeco Institutional Asset Management
37
Robeco Institutional Asset Management
Netherlands
$28.4M +$4.3M +33,819 +21%
Point72 Asset Management
38
Point72 Asset Management
Connecticut
$28.4M +$24.4M +191,999 New
Principal Financial Group
39
Principal Financial Group
Iowa
$28.2M +$775K +6,096 +3%
PPA
40
Parametric Portfolio Associates
Washington
$25.9M +$259K +2,039 +1%
Morgan Stanley
41
Morgan Stanley
New York
$25.7M -$43.6M -342,588 -66%
Deutsche Bank
42
Deutsche Bank
Germany
$25.1M +$1.11M +8,755 +5%
Ameriprise
43
Ameriprise
Minnesota
$25.1M +$288K +2,263 +1%
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$24.1M +$3.74M +29,417 +22%
Swiss National Bank
45
Swiss National Bank
Switzerland
$23.9M -$508K -4,000 -2%
Charles Schwab
46
Charles Schwab
California
$23.4M +$1.05M +8,243 +5%
TCIM
47
TIAA CREF Investment Management
New York
$20.6M -$175K -1,377 -1%
CCMH
48
Cornerstone Capital Management Holdings
New York
$20.3M +$5.31M +41,731 +44%
NIPH
49
NN Investment Partners Holdings
Netherlands
$20.1M +$16.1M +126,522 +1,338%
T. Rowe Price Associates
50
T. Rowe Price Associates
Maryland
$19.7M -$6.14M -48,305 -27%
1
2
3 4 5

UTHR Hedge Fund Activity: Q4 2017 in Review

400 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q4 2017, worth a combined $6.44B — up 26% from $5.13B a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new UTHR positions and 32 closed out — a net gain of 30 holders — while 135 added to existing stakes and 139 trimmed.

The largest buyer was Skandinaviska Enskilda Banken (SEB), adding an estimated $47.1M. The largest seller was Morgan Stanley, cutting an estimated $43.6M.

  • 400 institutional investors held United Therapeutics (UTHR) as of Q4 2017, up from 373 in Q3 2017.
  • Funds reported $6.44B of United Therapeutics stock for Q4 2017, up 26% quarter-over-quarter.
  • 62 funds opened new United Therapeutics positions in Q4 2017 and 32 closed out, a net change of +30 holders.
  • The largest United Therapeutics buyer in Q4 2017 was Skandinaviska Enskilda Banken (SEB), an estimated $47.1M added.
  • The largest United Therapeutics seller in Q4 2017 was Morgan Stanley, an estimated $43.6M sold.

Based on aggregated 13F filings for Q4 2017.